Dr. Douglas Swartz, MD
What this data tells you about Dr. Swartz
Dr. Douglas Swartz is an urology physician in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Swartz performed 11,297 Medicare services across 2,418 unique beneficiaries.
Between the years covered by Open Payments, Dr. Swartz received a total of $140,629 from 38 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swartz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,560 | $19 | $75 |
| BCG treatment for bladder cancer | 2,550 | $2 | $10 |
| Office visit, established patient (30-39 min) | 1,304 | $92 | $406 |
| Automated urinalysis | 1,111 | $2 | $15 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 365 | $132 | $587 |
| Hospital follow-up visit, moderate complexity | 192 | $63 | $224 |
| Initial hospital admission, moderate complexity | 155 | $100 | $426 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 152 | $25 | $100 |
| Bladder ultrasound after voiding | 145 | $7 | $60 |
| Office visit, established patient (20-29 min) | 112 | $63 | $287 |
| Blood draw (venipuncture) | 95 | $8 | $10 |
| Diagnostic exam of bladder and urethra using an endoscope | 95 | $175 | $739 |
| Hospital follow-up visit, low complexity | 75 | $39 | $119 |
| New patient office visit (30-44 min) | 62 | $75 | $355 |
| Drug injection, under skin or into muscle | 52 | $11 | $44 |
| Instillation of anti-cancer drug into bladder | 51 | $68 | $282 |
| Simple insertion of temporary bladder tube | 29 | $43 | $200 |
| Complete ultrasound scan behind abdominal cavity | 28 | $75 | $350 |
| Ct scan of abdomen and pelvis before and after contrast | 26 | $247 | $1,152 |
| New patient office visit (45-59 min) | 19 | $131 | $530 |
| X-ray of abdomen, 1 view | 17 | $22 | $92 |
| Ct scan of abdomen and pelvis without contrast | 17 | $135 | $611 |
| Imaging of urinary tract following injection of a contrast agent | 17 | $19 | $237 |
| Ultrasound scan of pelvic region through rectum | 17 | $98 | $430 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 16 | $138 | $2,547 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 13 | $244 | $5,731 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $569 | $2,829 |
| Needle biopsy of prostate gland using image guidance | 11 | $298 | $1,208 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (97%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for urology physician in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Swartz is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (consulting-driven, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Swartz experienced with denosumab injection (prolia/xgeva)?
Does Dr. Swartz receive payments from pharmaceutical companies?
How do Dr. Swartz's costs compare to other urology physicians in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology